世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3935 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、mRNAがんワクチン・治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん治療用標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途別市場規模（感染症、がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・mRNAがんワクチン・治療薬の市場動向 ・企業の競争状況、市場シェア ・mRNAがんワクチン・治療薬の種類別市場規模（がん治療用標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン） ・mRNAがんワクチン・治療薬の用途別市場規模（感染症、がん、その他） ・mRNAがんワクチン・治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・mRNAがんワクチン・治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・mRNAがんワクチン・治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・mRNAがんワクチン・治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・mRNAがんワクチン・治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology） ・結論

Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market
The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global mRNA Cancer Vaccines and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global mRNA Cancer Vaccines and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global mRNA Cancer Vaccines and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global mRNA Cancer Vaccines and Therapeutics market.

Global mRNA Cancer Vaccines and Therapeutics Scope and Market Size
mRNA Cancer Vaccines and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Cancer Vaccines and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Segment by Application
Infectious Disease
Cancer
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Standardization Of Cancer Treatment MRNA Vaccine
1.2.3 Individualized Cancer Treatment MRNA Vaccine
1.2.4 Infectious Disease Treatment MRNA Vaccine
1.2.5 Infection Prevention MRNA Vaccine
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2016-2027)
2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 mRNA Cancer Vaccines and Therapeutics Industry Dynamic
2.3.1 mRNA Cancer Vaccines and Therapeutics Market Trends
2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2020
3.5 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2022-2027)

5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type
6.2.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application
6.3.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.4.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
7.2.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.4.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type
8.2.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application
8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
8.4.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type
9.2.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application
9.3.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.4.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type
10.2.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application
10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.4.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
11.10.5 Tiba Biotechnology Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Standardization Of Cancer Treatment MRNA Vaccine
Table 3. Key Players of Individualized Cancer Treatment MRNA Vaccine
Table 4. Key Players of Infectious Disease Treatment MRNA Vaccine
Table 5. Key Players of Infection Prevention MRNA Vaccine
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2016-2021)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2022-2027)
Table 12. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 13. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 14. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 15. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 16. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2020)
Table 19. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
Table 23. Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Moderna Therapeutics Company Details
Table 64. Moderna Therapeutics Business Overview
Table 65. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 66. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Moderna Therapeutics Recent Development
Table 68. CureVac Company Details
Table 69. CureVac Business Overview
Table 70. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 71. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 72. CureVac Recent Development
Table 73. Translate Bio Company Details
Table 74. Translate Bio Business Overview
Table 75. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 76. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Translate Bio Recent Development
Table 78. BioNTech Company Details
Table 79. BioNTech Business Overview
Table 80. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 81. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 82. BioNTech Recent Development
Table 83. Sangamo Therapeutics Company Details
Table 84. Sangamo Therapeutics Business Overview
Table 85. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 86. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Sangamo Therapeutics Recent Development
Table 88. Argos Therapeutics Company Details
Table 89. Argos Therapeutics Business Overview
Table 90. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 91. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Argos Therapeutics Recent Development
Table 93. In-Cell-Art Company Details
Table 94. In-Cell-Art Business Overview
Table 95. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 96. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 97. In-Cell-Art Recent Development
Table 98. eTheRNA Company Details
Table 99. eTheRNA Business Overview
Table 100. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 101. eTheRNA Recent Development
Table 102. Ethris Company Details
Table 103. Ethris Business Overview
Table 104. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 105. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Ethris Recent Development
Table 107. Tiba Biotechnology Company Details
Table 108. Tiba Biotechnology Business Overview
Table 109. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 110. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Tiba Biotechnology Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Standardization Of Cancer Treatment MRNA Vaccine Features
Figure 3. Individualized Cancer Treatment MRNA Vaccine Features
Figure 4. Infectious Disease Treatment MRNA Vaccine Features
Figure 5. Infection Prevention MRNA Vaccine Features
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Infectious Disease Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 11. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2020
Figure 16. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2020
Figure 18. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
Figure 22. North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
Figure 23. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2016-2027)
Figure 24. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Region (2016-2027)
Figure 40. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 60. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 61. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 62. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 63. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 64. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 65. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 66. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 67. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 68. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---